Back to search

Italy· 046679015

METILPREDNISOLONE DOC

A methylprednisolone product containing metilprednisolone, registered in Italy by DOC GENERICI S.R.L., on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC H02AB04

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedMETILPREDNISOLONE DOCATCH02AB04REGISTER NO.046679015PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Methylprednisolone is registered in 15 of 19 countries.

Countries holding a registration under ATC H02AB04 (methylprednisolone), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 9 of them publish a price we can compare per daily dose

Methylprednisolone · ATC H02AB04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylprednisolone costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.13 in Italy to $0.85 in Switzerland — a ×6.4 gap.

  • Italy: $0.13 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Methylprednisolone · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.85
  • IT Italy$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Metilprednisolone
Manufacturer
DOC GENERICI S.R.L.
Country
Italy (IT)
ATC code
H02AB04
ATC class
Methylprednisolone
Defined daily dose
7.5 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    046679015
    "4 MG COMPRESSE" 30 COMPRESSE IN BLISTER PC/PVDC/AL
    EUR 4.13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

802 interactions on record for methylprednisolone.

Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylprednisolone · interactions on record

802 records

  • 84 severe
  • 367 moderate
  • 43 minor
  • 288 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • DesirudinB01AE01severe
  • ConivaptanC03XA02severe
  • Magnesium hydroxideA02AA04moderate

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylprednisolone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Advantan, Advantan Milch
  • Belgium · Advantan, Depo-Medrol
  • Bulgaria · Адвантан, Адвантан Мляко
  • Cyprus · Advantan, Fodier
  • Czechia · Advantan, Advantan Mléko
  • Germany · Advantan, Advantan Milch
  • Denmark · Depo-Medrol, Medrol
  • Estonia · Advantan, Advantan Milk
  • Spain · Adventan, Avatop
  • Finland · Advantan, Depo-Medrol
  • France · Depo-Medrol, Medrol
  • United Kingdom (Northern Ireland) · Depo-Medrone, Medrone
  • Greece · Advantan, Fodier
  • Croatia · Advantan, Depo-Medrol
  • Hungary · Advantan, Depo-Medrol
  • Ireland · Depo-Medrone, Solu-Medrone
  • Iceland · Depo-Medrol, Solu-Medrol
  • Lithuania · Advantan, Advantan Milk
  • Luxembourg · Advantan, Depo-Medrol
  • Latvia · Advantan, Advantan Milk
  • Malta · Advantan, Depo-Medrone
  • Netherlands · Depo-Medrol, Methylprednisolon Ace
  • Norway · Depo-Medrol, Medrol
  • Poland · Advantan, Depo-Medrol
  • Portugal · Aceponato De Metilprednisolona Aristo, Advantan
  • Romania · Advantan, Advantan Milk
  • Sweden · Depo-Medrol, Medrol
  • Slovenia · Advantan, Depo-Medrol
  • Slovakia · Advantan, Depo-Medrol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de3d7aa5-2c32-47cf-91b8-26a60efcc434
GET /v1/drugs/de3d7aa5-2c32-47cf-91b8-26a60efcc434?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"4 MG COMPRESSE\" 30 COMPRESSE IN BLISTER PC/PVDC/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Metilprednisolone",
  "reference_pack": "30 UNITA' 4 MG - USO ORALE",
  "public_price_eur": 4.13,
  "ssn_reference_price_eur": 4.13
}

See everything about methylprednisolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.